Description
Letrozol CRCA Coated Tablets 2.5 mg. #30
Description: Letrozol CRCA Coated Tablets are a medication used to treat certain types of breast cancer in postmenopausal women. Each tablet contains 2.5 mg. of the active ingredient Letrozole. The tablets are coated to ensure proper absorption and effectiveness.
Indications: Letrozol is indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is often prescribed after surgery to reduce the risk of cancer recurrence. Letrozol works by decreasing estrogen production in the body, which can slow or stop the growth of cancer cells.
Dosage and Administration: The usual dose of Letrozol is 2.5 mg. taken once daily, with or without food. It is important to take the medication at the same time each day to maintain consistent levels in the body. Do not crush or chew the tablets, as they are coated for proper release of the medication. Follow your doctor’s instructions carefully when taking Letrozol.
Contraindications: Letrozol should not be used in premenopausal women, as it can interfere with normal hormone production. It is also contraindicated in patients with a known allergy to Letrozole or any of the other ingredients in the tablets. Letrozol should be used with caution in patients with liver or kidney impairment.
Side Effects: Common side effects of Letrozol may include hot flashes, fatigue, joint pain, and headache. These side effects are usually mild and improve with continued use of the medication. Rare but serious side effects may include bone fractures, high cholesterol levels, and osteoporosis. Contact your doctor if you experience any severe or persistent side effects while taking Letrozol.
Warnings and Precautions: Letrozol may cause dizziness or drowsiness, so use caution when driving or operating machinery until you know how the medication affects you. Avoid becoming pregnant while taking Letrozol, as it can harm the developing fetus. Use effective contraception during treatment and discuss any pregnancy plans with your doctor.
Drug Interactions: Letrozol may interact with certain medications, including tamoxifen, estrogen-containing therapies, and some anticoagulants. Inform your doctor of all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions with Letrozol.
Storage: Store Letrozol tablets at room temperature, away from moisture and heat. Keep the tablets in their original packaging to protect them from light. Do not use Letrozol if the packaging is damaged or if the tablets appear discolored or have an unusual odor.
Conclusion: Letrozol CRCA Coated Tablets 2.5 mg. are a valuable medication for the treatment of hormone receptor-positive breast cancer in postmenopausal women. When used as directed and under the supervision of a healthcare provider, Letrozol can help reduce the risk of cancer recurrence and improve outcomes for patients. If you have been prescribed Letrozol, be sure to follow your doctor’s instructions closely and contact them with any questions or concerns about your treatment.
